This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(21), 6742-53
Citation
Lu, Hailing; Yang, Yi; Gad, Ekram; Inatsuka, Carol; Wenner, Cynthia A; Disis, Mary L; Standish, Leanna J. (2011). TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.. Clinical cancer research : an official journal of the American Association for Cancer Research, 17(21), 6742-53. https://doi.org/10.1158/1078-0432.CCR-11-1142